200 related articles for article (PubMed ID: 17276395)
1. A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.
Osada M; Park HL; Park MJ; Liu JW; Wu G; Trink B; Sidransky D
Biochem Biophys Res Commun; 2007 Mar; 354(4):913-8. PubMed ID: 17276395
[TBL] [Abstract][Full Text] [Related]
2. A novel response element confers p63- and p73-specific activation of the WNT4 promoter.
Osada M; Park HL; Nagakawa Y; Begum S; Yamashita K; Wu G; Kim MS; Trink B; Sidransky D
Biochem Biophys Res Commun; 2006 Jan; 339(4):1120-8. PubMed ID: 16343436
[TBL] [Abstract][Full Text] [Related]
3. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
4. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.
Ciribilli Y; Monti P; Bisio A; Nguyen HT; Ethayathulla AS; Ramos A; Foggetti G; Menichini P; Menendez D; Resnick MA; Viadiu H; Fronza G; Inga A
Nucleic Acids Res; 2013 Oct; 41(18):8637-53. PubMed ID: 23892287
[TBL] [Abstract][Full Text] [Related]
5. Mouse DDA3 gene is a direct transcriptional target of p53 and p73.
Hsieh SC; Lo PK; Wang FF
Oncogene; 2002 May; 21(19):3050-7. PubMed ID: 12082536
[TBL] [Abstract][Full Text] [Related]
6. Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family.
Schilling T; Schleithoff ES; Kairat A; Melino G; Stremmel W; Oren M; Krammer PH; Müller M
Biochem Biophys Res Commun; 2009 Sep; 387(2):399-404. PubMed ID: 19615968
[TBL] [Abstract][Full Text] [Related]
7. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes.
Sasaki Y; Naishiro Y; Oshima Y; Imai K; Nakamura Y; Tokino T
Oncogene; 2005 Jul; 24(32):5131-6. PubMed ID: 15856012
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
Mondal N; Parvin JD
Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
[TBL] [Abstract][Full Text] [Related]
9. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
10. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
11. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
12. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.
Jordan JJ; Menendez D; Inga A; Noureddine M; Bell DA; Resnick MA
PLoS Genet; 2008 Jun; 4(6):e1000104. PubMed ID: 18714371
[TBL] [Abstract][Full Text] [Related]
13. P53 family: at the crossroads in cancer therapy.
Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
[TBL] [Abstract][Full Text] [Related]
14. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
15. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73.
Dietz S; Rother K; Bamberger C; Schmale H; Mössner J; Engeland K
FEBS Lett; 2002 Aug; 525(1-3):93-9. PubMed ID: 12163168
[TBL] [Abstract][Full Text] [Related]
17. Structure, function and regulation of p63 and p73.
Levrero M; De Laurenzi V; Costanzo A; Gong J; Melino G; Wang JY
Cell Death Differ; 1999 Dec; 6(12):1146-53. PubMed ID: 10637429
[TBL] [Abstract][Full Text] [Related]
18. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
Zhang L; Nie L; Maki CG
Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
[TBL] [Abstract][Full Text] [Related]
19. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.
Kartasheva NN; Contente A; Lenz-Stöppler C; Roth J; Dobbelstein M
Oncogene; 2002 Jul; 21(31):4715-27. PubMed ID: 12101410
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
Vilgelm A; El-Rifai W; Zaika A
Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
